Jérome Amaudrut

6PUBLICATIONS
22CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsMolecular targetsBiomolecular modelling and designBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 15, 2026
Crystal Structure of the Sigma‑2 Receptor Complexed with Investigational Drug Zervimesine (CT1812).

|Aug 13, 2026
Discovery and Preclinical Characterization of I-0436650, a Selective SHP2 Allosteric Inhibitor for RAS-Driven Cancers.

|Jan 22, 2024
Viruses traverse the human proteome through peptide interfaces that can be biomimetically leveraged for drug discovery.

Laurène Meyniel-Schicklin, Jérôme Amaudrut, Pierre Mallinjoud

|May 17, 2023
Discovery of a Novel Series of Potent SHP2 Allosteric Inhibitors.

Alessia Petrocchi, Alessandro Grillo, Luca Ferrante

|Feb 16, 2023
Discovery of a Novel Series of Imidazopyrazine Derivatives as Potent SHP2 Allosteric Inhibitors.

Esther Torrente, Valentina Fodale, Alina Ciammaichella

|Feb 16, 2018
Design, Synthesis, and Evaluation of a Novel Series of Indole Sulfonamide Peroxisome Proliferator Activated Receptor (PPAR) α/γ/δ Triple Activators: Discovery of Lanifibranor, a New Antifibrotic Clinical Candidate.

Benaïssa Boubia, Olivia Poupardin, Martine Barth

Pageof 1

Frequent Collaborators

2 joint publications

Esther Torrente

1 joint publications

Benaïssa Boubia

1 joint publications

Romano Di Fabio

1 joint publications

Laurène Meyniel-Schicklin